Related references
Note: Only part of the references are listed.Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression
J. Liang et al.
BRITISH JOURNAL OF CANCER (2013)
Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
Shun-Jun Fu et al.
SURGERY (2013)
Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and Osteopontin
Ming-Chin Yu et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Prognostic significance of osteopontin in hepatocellular carcinoma: A meta-analysis
Chuan-Hai Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients
Su Ning et al.
MOLECULAR BIOLOGY REPORTS (2012)
Gene Expression Profiling of Liver Cancer Stem Cells by RNA-Sequencing
David W. Y. Ho et al.
PLOS ONE (2012)
Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation
Yu-Liang Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma
Kenji Yorita et al.
LIVER INTERNATIONAL (2011)
The Oncogenic Effect of Sulfatase 2 in Human Hepatocellular Carcinoma Is Mediated in Part by Glypican 3-Dependent Wnt Activation
Jin-Ping Lai et al.
HEPATOLOGY (2010)
Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation
Ivan Stigliano et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
Hirofumi Shirakawa et al.
CANCER SCIENCE (2009)
Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin/TCF
Yuichi Torisu et al.
CANCER SCIENCE (2008)
Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway
Wei Cheng et al.
CARCINOGENESIS (2008)
Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: A metaanalysis of randomized trials
YaJun E et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2008)
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
Josep M. Llovet et al.
GASTROENTEROLOGY (2006)
Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas
Xiao Ying Wang et al.
HUMAN PATHOLOGY (2006)
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients
G Varotti et al.
EJSO (2005)
Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling
MI Capurro et al.
CANCER RESEARCH (2005)
The loss of glypican-3 induces alterations in wnt signaling
HH Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A decade's studies on metastasis of hepatocellular carcinoma
ZY Tang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
T Nakatsura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling
Y Midorikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
RTP Poon et al.
ANNALS OF SURGERY (2000)
Share Paper
